Background/Aims: Soy isoflavones have been reported to prevent bone loss in rat models of osteoporosis. However, the effect of the natural soybeans that people consume in their diet needs to be explored. In the present study, we evaluated the effects of yellow and black soybeans (Glycine max), and sword beans (Canavalia gladiate) on bone mineral density (BMD), bone mineral content (BMC), and bone biomarkers in ovariectomized (OVX) rats. Methods: Seven-week-old female Sprague-Dawley rats were raised for 2 weeks on a calcium-free diet based on the American Institute of Nutrition (AIN)-93M diets. All the rats received OVX, were randomized to one of four groups, and given one of the diets supplemented with casein, yellow soybean, black soybean, and sword bean for 10 weeks. BMD, BMC, osteocalcin (OC; a bone formation biomarker), deoxypyridinoline (DPD; a bone resorption biomarker), and TNF-α (a bone resorption cytokine) were assessed. Results: In the femur and lumbar spine, BMD and BMC were significantly higher in the various bean groups than in the casein group. Among the bean groups, femur and spine BMD were significantly higher in the yellow soybean and sword bean groups than in the black soybean group. Femur BMC was the highest in the yellow soybean group, and spine BMC was not significantly different between the various bean groups. Plasma OC concentrations and urinary DPD excretion were significantly higher in the casein group than in the various bean groups. The sword bean group showed significantly lower OC and DPD levels than the yellow and black soybean groups. There were no significant differences between the yellow and black soybean groups. TNF-α concentrations were not significantly different between the four groups. Conclusion: Consumption of yellow and black soybeans, and sword beans had a definite protective effect on bone loss in OVX rats by inhibiting bone turnover and preventing bone resorption. Furthermore, consumption of sword beans may help prevent postmenopausal osteoporosis.

Keywords:
Black soybeans, Bone metabolism, Isoflavones, Osteoporosis, Ovariectomy, Sword beans, Yellow soybeans
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.